Promotion “Targets” Needed From Sponsors Throughout Development – FDA
This article was originally published in The Tan Sheet
Executive Summary
Sponsors should provide FDA with proposed promotional claims at the start of a drug development process, the agency says in a draft guidance applicable to new drug applications